Spirulina and ZIP8/ZIP14: Zinc and Manganese Importers, Lung Susceptibility, and Inflammatory Metal Trafficking

The ZIP Family: Structure and Transport Chemistry

The Zrt/Irt-like protein (ZIP) family comprises 14 members in humans (SLC39A1–14), all functioning as metal importers that move zinc, iron, manganese, or cobalt from extracellular space or intracellular vesicular compartments into the cytosol. Their shared architecture consists of eight transmembrane domains (TM1–8) with a characteristic HEXPHEXGD motif in TM5 that coordinates metal ions via histidine residues. Unlike the ZnT (SLC30A) efflux transporters, ZIPs lower cytosolic metal concentrations in the vesicular compartment relative to cytosol, or raise cytosolic concentrations relative to the extracellular space. ZIP8 (SLC39A8) and ZIP14 (SLC39A14) are distinguished from most family members by their unusually broad substrate specificity: both transport Zn²⁺, Mn²⁺, Fe²⁺, Cd²⁺, and Co²⁺, with kinetics that depend on cellular context and competing ion concentrations. ZIP8’s transport of manganese is particularly notable and clinically significant: loss-of-function variants in SLC39A8 cause a rare congenital disorder of glycosylation (CDG; OMIM 616721) characterised by hypomanganesaemia, severe intellectual disability, cerebellar atrophy, and dystonia, confirming that ZIP8-mediated Mn²⁺ import is essential for proper glycosylation of proteins in the Golgi (Mn²⁺-dependent glycosyltransferases require cytosolic Mn²⁺ that is ultimately translocated to the Golgi lumen by SPCA1/SLC30A9).

ZIP8 in the Lung: Respiratory Infection Susceptibility

ZIP8 is expressed at high levels in lung alveolar epithelium, bronchial epithelium, and pulmonary macrophages, placing it at the first line of defence against inhaled pathogens. Its expression is strongly induced by NF-κB-activating stimuli: TNF-α, IL-1β, LPS, and respiratory viral infections all upregulate ZIP8 transcription via NF-κB binding sites in the SLC39A8 promoter. The functional consequence is context-dependent. During cadmium exposure (cigarette smoke; industrial inhalation), ZIP8 facilitates Cd²⁺uptake into lung cells, causing mitochondrial dysfunction, apoptosis, and COPD-like injury. Genetically, a common missense variant A391T (rs13107325; Ala391Thr) reduces ZIP8 transport activity; this variant has been associated in GWAS studies with lower blood manganese levels and, paradoxically, with lower risk of some inflammatory conditions while associating with altered susceptibility to infections and to schizophrenia (manganese’s role in superoxide dismutase MnSOD/SOD2 may be mechanistically relevant). In the context of bacterial infection, ZIP8 in alveolar macrophages imports zinc, which is then sequestered by metallothioneins (MT1/2; Zn-sensing MTF1 transcription factor drives MT expression): this zinc sequestration is a form of nutritional immunity, limiting zinc availability to zinc-requiring pathogens in the phagosome. At the same time, ZIP8-mediated zinc influx activates NF-κB further (zinc-NF-κB crosstalk: Zn²⁺at low micromolar concentrations activates IKKβ), potentially creating a positive feedback loop during lung infection. The net outcome depends on the balance between zinc’s antimicrobial function and its pro-inflammatory signalling.

ZIP14 in Liver and Intestine: Inflammation-Driven Metal Sequestration

ZIP14 (SLC39A14) is highly expressed in hepatocytes and intestinal enterocytes and plays the dominant role in the acute-phase redistribution of zinc and manganese from circulation to the liver. During the acute-phase response, IL-6 signals via JAK1/STAT3 to the liver, and simultaneously TNF-α activates NF-κB; both transcription factors upregulate ZIP14 expression on the basolateral (sinusoidal) hepatocyte membrane, increasing zinc and Mn²⁺import from portal blood. This is the cellular mechanism underlying the well-documented hypozinaemia of inflammation: systemic zinc falls during infection and inflammation not because zinc is lost or demand increases, but because ZIP14 upregulation concentrates zinc in hepatocytes (and to a lesser degree in other reticuloendothelial cells). Hepatic zinc sequestration serves several functions: zinc is required for acute-phase protein synthesis (metalloproteases, C-reactive protein folding); zinc deprivation limits bacterial growth (nutritional immunity); and intracellular zinc participates in NF-κB signalling and immune cell co-ordination. Manganese sequestration by ZIP14 serves a parallel function: Mn²⁺-dependent pathogen enzymes (bacterial MnSOD; virulence factor Mn-requiring enzymes) are starved. ZIP14 knockout mice show impaired hepatic Mn²⁺ and zinc uptake, reduced acute-phase response, and altered infection outcomes, confirming its non-redundant immunological role.

Spirulina’s Zinc Content and Bioavailability Considerations

Spirulina contains zinc at approximately 0.3–0.5 mg per 5 g serving, varying with cultivation conditions and water mineral content. This represents 3–5% of the adult RDA (8–11 mg/day), making spirulina a modest rather than substantial zinc source. Bioavailability from spirulina, as with plant-sourced zinc generally, is estimated at 15–30% of total zinc content, limited by the presence of phytate (though spirulina contains far less phytate than cereals or legumes) and by the competition from other minerals. The zinc in spirulina exists partly bound to proteins (metalloproteins in the cyanobacterial proteome) and partly in ionic form; protein-bound zinc may have moderately better bioavailability than inorganic zinc salts in some models. An important zinc co-factor in spirulina is superoxide dismutase itself: spirulina contains Cu/Zn-SOD (SOD1 in human terminology), though whether the intact bacterial enzyme survives gastric digestion to deliver catalytically active enzyme is debatable; the zinc and copper liberated on digestion are bioavailable even if the enzyme is not. Spirulina’s manganese content is approximately 0.02–0.05 mg per 5 g, negligible relative to the adequate intake (1.8–2.3 mg/day from food).

Spirulina’s NF-κB Suppression and ZIP14 Metal Trafficking

Phycocyanin inhibits IKKβ phosphorylation and thereby reduces NF-κB p65 nuclear translocation. Since ZIP14 transcription is upregulated by NF-κB during inflammation, spirulina’s anti-inflammatory programme would theoretically attenuate ZIP14 upregulation in inflammatory contexts, moderating the degree of hepatic zinc sequestration during infection. This is a biologically plausible but empirically understudied prediction: no published study has directly measured ZIP14 expression in spirulina-supplemented animals challenged with an acute-phase stimulus. What can be reasonably inferred is that spirulina’s suppression of IL-6 and TNF-α (demonstrated in multiple human RCTs: IL-6 −15–30%, TNF-α −20–35%) will secondarily attenuate JAK/STAT3 and NF-κB-driven ZIP14 upregulation in the liver, mildly blunting the inflammatory hypozinaemia response. Whether this is beneficial (preventing unnecessary zinc restriction of immune effectors) or marginally detrimental (allowing more zinc to remain available to pathogens) depends on the infection type and stage. The same NF-κB suppression in lung tissue would reduce ZIP8 induction during pulmonary inflammation, potentially limiting cadmium uptake in smokers but also moderating zinc-dependent antimicrobial responses in alveolar macrophages. Spirulina’s own zinc contribution, though modest, adds to the systemic zinc pool, and adequate systemic zinc independently supports metallothionein-based zinc buffering, ZIP-family transporter regulation through MTF1, and the zinc finger transcription factors central to immune gene expression.

Practical Takeaway: What Spirulina Users Should Know

Spirulina is not a clinically significant zinc supplement by itself; those with documented zinc deficiency need dedicated zinc supplementation (elemental zinc 15–30 mg/day). However, its anti-inflammatory effects on NF-κB have a genuine secondary impact on how the body distributes the zinc it does have, particularly during infection or chronic inflammatory conditions where ZIP14 upregulation continuously pools zinc in the liver at the expense of circulating levels. People with conditions characterised by chronic low-grade inflammation — metabolic syndrome, type 2 diabetes, chronic infections — exhibit persistent hypozinaemia that is partly ZIP14-mediated rather than purely dietary; spirulina’s anti-inflammatory programme may contribute to restoring more physiological zinc distribution in this context, consistent with the modest improvements in serum zinc reported in some diabetic patient trials (+0.1–0.3 μg/mL). For ZIP8 in the lung, the key practical message is that spirulina’s broad NF-κB suppression extends to pulmonary epithelium, where it may reduce cadmium-entry risk via ZIP8 downregulation in current or former smokers, a hypothesis worth formal investigation.